Top Banner
Scleroderma Patient Education Event Pulmonary Arterial Hypertension Overview Michael J. Cuttica MD Assistant Professor of Medicine Northwestern Pulmonary Hypertension Program Northwestern University October 18, 2013
23

Pulmonary Arterial Hypertension Overview for Scleroderma Patients

Jan 28, 2015

Download

Health & Medicine

Pulmonary Arterial Hypertension Overview
Michael J. Cuttica MD Assistant Professor of Medicine Northwestern Pulmonary Hypertension Program
Northwestern University
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

Scleroderma Patient Education Event

Pulmonary Arterial Hypertension Overview

Michael J. Cuttica MD Assistant Professor of Medicine

Northwestern Pulmonary Hypertension Program Northwestern University

October 18, 2013

Page 2: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

Outline

• 1. Pulmonary Arterial Hypertension Defined

• 2. Diagnosis of PAH

• 3. Treatment of PAH

Page 3: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

What is Pulmonary Hypertension?

• PH is high blood pressure in the blood vessels in the lungs.

• The blood pressure in your lung is normally very low: – about 1/5 your systemic blood pressure

• Many disease processes can cause the pulmonary blood pressure to rise.

Page 4: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

What is the Anatomy?

Systemic BP:

Systolic 120 mmHg

Diastolic 80 mmHg

Mean 65 mmHG

Pulmonary Artery Pressure:

Systolic 20-30 mmHg

Diastolic 5-15 mmHg

PA (mean) <25 mmHG

Page 5: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

Updated Clinical Classification of Pulmonary Hypertension

(Dana Point 2008)

Class 1. Pulmonary Arterial Hypertension

Class 2. Pulmonary Hypertension with Left Heart

Disease

Class 3. Pulmonary Hypertension associated with lung

disease and/or hypoxemia

Class 4. Pulmonary Hypertension due to chronic

thrombotic and/or embolic disease

Class 5. Pulmonary Hypertension with unclear or

multifactorial mechanisms (sarcoid, MPD, CRF on HD)

Class 1:

Pulmonary Arterial Hypertension

1.1 Idiopathic (IPAH)

1.2 Heritable: BMPR2, ALK1/endoglin, Unknown

1.3 Drug and toxin induced:

1.4 Associated with:

1.4.1: Connective Tissue Disease

1.4.2: HIV infection

1.4.3: Portal HTN

1.4.4: Congenital heart disease

1.4.5: Schistosomiasis

1.4.6: Chronic hemolytic anemia

1.5 Persistent PH of the newborn

1’ PVOD and or PCH

Page 6: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

Where is the disease?

Class 1: PAH

Class 2: PVH

Class 3: PH Class 4: CTEPH

Class 5: PH – Multifact.

Page 7: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

Clinical Classification of Pulmonary

Hypertension (Dana Point, 2008)

Class 1: PAH

mPAP at rest > 25mmHg

mPAP with exercise > 30mmHg

PCWP < 15mmHg

PVR >3 Wood units

Class 2: PVH

mPAP at rest > 25mmHg

PCWP > 15mmHg

Class 3: PH associated with lung disease

mPAP at rest > 20mmHg

Underlying chronic lung disease: COPD, ILD, Alveolar Hypoventilation Syndromes, Sleep disordered breathing

Pulmonary Vascular Resistance (PVR): Change in pressure/ flow Right heart Pressure – Left heart Pressure Cardiac Output

Page 8: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

What Causes PAH?

• Four Factors are thought to cause the increased pulmonary vascular resistance that characterizes the disease:

1.Vasoconstriction • Under expression of vasodilators like NO and prostacyclin

• Over expression of vasoconstrictors endothelin-1

2.Remodeling of pulmonary vessel wall

3.Thrombosis in situ

4. Inflammation

Page 9: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

What is “remodeling” of a pulmonary vessel?

Medial hypertrophy • Abnormal Smooth

Muscle Cell growth

• Extension of smooth muscle into small PA’s

• Abnormal Endothelial cell growth

– monoclonal origin

• Inflammatory Cell infiltration around plexiform lesions.

• In situ thrombosis– clots.

PAH Normal

Page 10: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

What is the Clinical Presentation of PAH?

Breathlessness Without overt signs of heart and lung disease

Fatigue

Weakness

Angina/Chest Pain

Edema/Swelling

Syncope/passing out

Clinical Suspicion of

PAH

Page 11: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

Why do Patients with PAH get short of breath?

Your lungs are the source of oxygen that your body needs for physical activity Oxygen from your lungs enters your blood as it flows through microscopic blood vessels called capillaries that surround tiny air sacs called alveoli.

Page 12: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

Reduced Blood Flow Means Less Oxygen

If you have PAH, it is harder for blood to reach your lungs and pick up oxygen because the pulmonary arteries become so narrow, the resistance increases, and blood can not flow quickly through them. Over time, this increased resistance to blood flow puts a strain on the right side of the heart as it has to work extra hard to push blood through the lungs.

Page 13: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

Right Heart Strain

As the right heart is strained over time we see it dilate/enlarge and we see the function/squeeze of the right heart decrease. With less oxygen in the blood stream and the right heart pumping less forcefully patients feel tired more often and get short of breath quickly, especially when exerting themselves.

Page 14: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

How Do We Diagnose PAH?

• Typically, you undergo a series of tests to determine if you have PAH or another illness with symptoms similar to PAH.

• Making this determination is very important as treatments for different conditions are very different.

• Primary tests usually done first are: – echocardiogram and pulmonary function testing.

Page 15: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

What is an Echocardiogram?

• Uses sound waves to create a picture of your heart and measure blood flow

• Provides useful information about the structure and function of your heart

• Can provide an estimation of the pressures in your pulmonary artery.

Dilated Right ventricle with reduced function

Page 16: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

What is Pulmonary Function Testing?

• Determine the flow of air in and out of the lung – ? Obstructive lung disease

• Determine the volume of air in the lung – ? Restrictive lung disease

• How well does oxygen go from your lungs and into your blood? – ? Vascular health of the lung

Page 17: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

What is a Right Heart Catheterization (RHC)?

• RHC is the gold standard test for making the diagnosis of PAH.

– It is absolutely necessary before initiation of any PAH specific therapy

• This test allows us to measure the blood pressure in your lungs directly.

• It allows us to calculate how much blood your heart is pumping in every minute.

Page 18: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

What is a RHC?

• A thin catheter is inserted through a large IV either in the neck or groin.

• This catheter is then guided through the right heart and into the pulmonary artery

• Typically, a RHC can be performed in less than 1 hour.

• Occasionally, an additional catheter will be inserted into an artery to measure pressures on the left side of the heart.

Page 19: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

What is the Anatomy?

Right Atrium: 2-8 mmHg

PCWP: 6-12mmHg (must be <PA diastolic)

Left Atrium: 6-10mmHg

Left Ventricle: Systolic 120 mmHG

Diastolic 6-12mmHg

Pulmonary Artery Pressure: Systolic 20-30 mmHg

Diastolic 5-15 mmHg

PA (mean) <25 mmHG

Page 20: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

What Other Tests Might be ordered?

• EKG/Electrocardiogram

• CT scan of chest

• Chest X-ray

• V/Q scan

• Sleep study

Looks for signs of Right heart

strain

Imaging of the chest to look

for lung disease.

Looking for blood clots

Sleep issues like sleep apnea

are associated with PH

Page 21: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

How do we treat PAH?

• The goal of treatment for PAH is to relieve symptoms and slow the progression of disease.

• Initial treatment decisions are based on how far the disease has progressed and how symptomatic a patient is.

• Treatment options include: – Oral therapies: pills

– Inhaled therapies

– Continuous IV or subcutaneous infusion

– Surgery: lung transplant

Page 22: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

Humbert M et al. N Engl J Med 2004;351:1425-1436

Page 23: Pulmonary Arterial Hypertension Overview for Scleroderma Patients

Conclusions

• Pulmonary hypertension is high blood pressure in the blood vessels in the lungs

• Patients with scleroderma are at an increased risk for developing this complication

• The diagnosis of this disease is made by excluding other causes of symptoms and by right heart catheterization

• Great advances in treatment have been made in the last 10-15 years